Adding the measurement that post #3 says would settle it. What would change my mind on batch numbers is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.
Batch numbers that do not match the vial label — setting out what I have, and where I think it stops being reliable.
Structured question about turnaround and what it signals.
I have started recording how long a technical request takes to answer and whether the answer contains a number. Across 18 requests the distribution is more bimodal than I expected.
Is response quality a defensible proxy for anything, or am I measuring who happens to be at a desk?
Picking up the opening post: that is the part I would want checked first.
Source for the batch numbers figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.
Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.
Coming back to the opening post, because the follow-up matters more than the original answer.
Reporting something here requires the batch, the date, the method and the document, which is exactly what makes the reports worth reading two years later.
The general answer and the answer for your case may diverge here.
Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong strength, or wrong batch on the label), and failure to provide documentation when asked.
Adding this to the thread rather than to the wiki, because I am not confident enough for the wiki.
Two claims get bundled together under batch numbers and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.
Almost every disagreement in threads like this one dissolves once you say which of the two you are making.
Answering the question post #7 raises rather than the one it answers.
On batch numbers, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.
If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.
Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation about intent and nothing in a chromatogram supports it.
Post #8 is the version of this I will quote in future. One addition.
A supplier changing batch nomenclature is not a warning sign, and it does make historical comparison harder until a mapping exists.
The conclusion is tentative; the arithmetic underneath it is not.
Adding a reference point for batch numbers. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
Useful. I had the fact and not the reason, which turns out to be the important half.
Post #14 put the caveat in the right place and I want to underline it.
Where the same certificate image appears with different lot numbers, that is a documentation finding worth reporting with the images attached.
Where I would look next, rather than where I would stop.
The arithmetic in post #16 is right; the assumption feeding it is the part to check.
One more thing on batch numbers that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.
Summarising the batch numbers thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.
The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not.
Practical experience of batch numbers, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth documenting.
Answering the question post #19 raises rather than the one it answers.
A certificate whose lot number does not match the vial is a stop-and-ask, not a conclusion. Most such things are warehouse paperwork.
That is all the detail I have. Someone else will have more.
The arithmetic in post #23 is right; the assumption feeding it is the part to check.
Batch numbers: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Post #23 and I disagree about the size of the effect, not about the direction.
Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong strength, or wrong batch on the label), and failure to provide documentation when asked.
I would want a second opinion before relying on that.
Following this. I have the same question and no better information than the first post.
Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
Worth checking against a second source before it gets quoted onward.
This follows post #27 rather than contradicting it.
The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
I would want the raw data before agreeing with my own summary of it.